Brean Murray initiates coverage on Allscripts-Misys Healthcare (Nasdaq: MDRX) with a Buy.

Brean analyst says, "We believe the company’s merger ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE